Starting from January, 2009, Jinan Trio Pharmatech.co., Ltd. has engaged in developing heterocyclic compounds. To date, over 1000 compounds have been produced. Main costumers are located in Europe and Northern America, including multinational pharmaceutical companies, such as Pfizer, Johnson & Johnson, Merck, GlaxoSmithKline, et al. These compounds have been used to develop novel drugs for human and veterinary medicines, as well as pesticides.

After competitive application, the Chairman of the Board was successfully awarded the fund from "Attracting High-Level Talent 5150 Scheme" and honored as a "Spring-City" Specialist" by the government of Jinan City, in November, 2010. From then on, the company has been receiving the finance and policy supports from the government.

The company has a consummate management system, and is now led by a core group of top overseas pharmaceutical chemists, medical scientists and business management experts. It is actively participating in the industry chain of international pharmaceutical companies, with its people-oriented and research-led concepts.

The company has denoted itself in supporting customers with high quality products and serves at competitive prices. It has build up solid cooperation with several domestic and international universities and research institutes. It is focused on developing novel highly selective molecular targeted anti-cancer drugs, their intermediates and heterocyclic compounds. These drugs have less side-effects and higher selectivity, compared to the traditional chemotherapeutic drugs. The study on this type of drugs has become the hotspot in the cancer research field, and will definitely become the predominant products in the international anti-cancer drug markets.

New business has launched regarding novel anti-cancer drugs, such as transferring inventive patents and technical cooperation. Our aim is to build the company as a corporation of R&D, manufacture, sale and technical training. Our long-term objective is to supply novel anti-cancer drugs at competitive prices, high efficiency and low toxicity, to the people worldwide, particularly those in the developing countries.

Our motto is "Research, Innovation, Green and Health".